India ranks 19th in Index of Cancer PreparednessDate: 22 April 2019 Tags: Reports & Indices
India was ranked at 19 out of 28 countries in Index of Cancer Preparedness (ICP) released by the Economist Intelligence Unit (EIU). It was released as part of the report titled “Cancer preparedness around the world: National readiness for a global epidemic” prepared by EIU.
Index of Cancer Preparedness (ICO)
- Its objective is to allow benchmarking of national efforts and identify best practice in addressing the cancer challenge. It took 28 countries into consideration.
- It explores issue of cancer preparedness through three broad domains: (i) policy and planning; (ii) care delivery; and (iii) health systems and governance.
- Under it, four essentials of cancer preparedness are: (i) investment i.e. appropriate spending and resources), (ii) roadmap for effective planning), (iii) foundation for functioning health systems and (iv) intelligence in availability and quality of cancer-related data).
- Findings on overall best practices for cancer preparedness: Top 3 countries are: Australia (1st), Netherlands (2nd) and Germany (3rd).
- Bottom three are: Saudi Arabia (28th), Romania (27th) and Egypt (26th). These counties need largest room for improvement.
- India and ICP: Its overall rank was 19th with a score of 64.9. India ranked 17th in cancer policy and planning.
- India has relatively high score of 80.8 and it largely stems from its strong cancer research and tobacco control measures.
- India ranked first for research and third for tobacco control. It ranks 23rd for its national cancer control plan.
- India’s healthcare system was ranked 25th in the index. In its delivery of cancer care, it was ranked 20th with a score of 61.3.
- India’s healthcare infrastructure is the second worst among these countries. It has high standard of clinical guidelines category where it is ranked first. But it falls short on immunization, screening and early detection.
It is generic term for large group of diseases characterized by growth of abnormal cells beyond their usual boundaries that can then invade adjoining parts of body and spread to other organs. It is world’s second biggest killer, responsible for 9.6 million deaths in 2018–roughly i.e. one out of six across globe. It is second largest cause of mortality before the age of 70 in over half the world’s countries.